Detalles de la búsqueda
1.
Impact of metabolic dysfunction-associated fatty liver disease on the incidence of Helicobacter pylori-negative gastric cancer.
Hepatol Res
; 54(6): 540-550, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38156966
2.
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.
Hepatol Res
; 54(4): 326-335, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975277
3.
Impact of non-obese metabolic dysfunction-associated fatty liver disease on risk factors for the recurrence of esophageal squamous cell carcinoma treated with endoscopic submucosal dissection: A multicenter study.
Hepatol Res
; 54(2): 201-212, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796562
4.
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease.
Hepatol Res
; 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661715
5.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149726
6.
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease.
Hepatol Res
; 53(5): 391-400, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707103
7.
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Hepatol Res
; 53(11): 1059-1072, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537735
8.
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia study.
J Gastroenterol Hepatol
; 38(6): 896-904, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36797989
9.
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.
J Gastroenterol Hepatol
; 38(10): 1832-1839, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596843
10.
MAFLD: Renovation of clinical practice and disease awareness of fatty liver.
Hepatol Res
; 52(5): 422-432, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34472683
11.
Metabolic dysfunction-associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients.
Hepatol Res
; 52(10): 841-858, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815420
12.
Lean/normal-weight metabolic dysfunction-associated fatty liver disease is a risk factor for reflux esophagitis.
Hepatol Res
; 52(8): 699-711, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585481
13.
Hepatic expression of sodium-glucose cotransporter 2 (SGLT2) in patients with chronic liver disease.
Med Mol Morphol
; 55(4): 304-315, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36131166
14.
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
Semin Liver Dis
; 41(3): 225-234, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147036
15.
Association between the albumin-bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data-mining analysis.
Hepatol Res
; 51(12): 1207-1218, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34534392
16.
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach.
Hepatol Res
; 51(11): 1115-1128, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34129272
17.
Effects of a low-intensity resistance exercise program on serum miR-630, miR-5703, and Fractalkine/CX3CL1 expressions in subjects with No exercise habits: A preliminary study.
Hepatol Res
; 51(7): 823-833, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014020
18.
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
J Gastroenterol Hepatol
; 36(3): 629-636, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32627871
19.
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.
Liver Int
; 40(12): 3018-3030, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997882
20.
A Sharp Solution for a Pointed Problem: Foreign Body Removal From an Infant's Upper Gastrointestinal Tract.
Am J Gastroenterol
; 117(9): 1404, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416800